Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 20/20 | 0.85 |
| ▸ | TACR2 | P21452 | 12/20 | 0.85 |
| ▸ | TACR3 | P29371 | 11/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | TAC3 | Q9UHF0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15397600 | 1.00 | TACR1 (0.85) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL15397494 | 1.00 | TACR1 (0.85) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL15397477 | 0.96 | TACR1 (0.79) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL15397476 | 0.96 | TACR1 (0.79) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL15397607 | 0.95 | TACR3 (0.77) | TACR1TACR2TACR3 | |
| SCHEMBL15397468 | 0.95 | TACR1 (0.77) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL15397469 | 0.95 | TACR1 (0.77) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL15397606 | 0.95 | TACR3 (0.77) | TACR1TACR2TACR3 | |
| SCHEMBL1968578 | 0.94 | TACR1 (0.86) | TACR1TACR2TACR3CYP3A4CYP2D6 | |
| SCHEMBL1968581 | 0.94 | TACR1 (0.86) | TACR1TACR2TACR3CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49686-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| US-RE48334-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-12-01 | — | — | US | disclosed |
| EP-2336105-B9 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE OF SAME | TAKEDA PHARMACEUTICAL (JP) | 2014-09-17 | — | — | EP | disclosed |
| EP-2336105-B1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE OF SAME | TAKEDA PHARMACEUTICAL (JP) | 2014-02-12 | — | — | EP | disclosed |
| US-8592454-B2 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-11-26 | — | — | US | disclosed |